RDHL - RedHill Biopharma Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5203.95M
Enterprise Value 3157.25M
Trailing P/E N/A
Forward P/E 1-8.59
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)26.65
Price/Book (mrq)4.76
Enterprise Value/Revenue 320.55
Enterprise Value/EBITDA 6-4.11

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-503.78%

Management Effectiveness

Return on Assets (ttm)-46.10%
Return on Equity (ttm)-99.16%

Income Statement

Revenue (ttm)7.65M
Revenue Per Share (ttm)0.31
Quarterly Revenue Growth (yoy)-29.00%
Gross Profit (ttm)5.52M
EBITDA -38.25M
Net Income Avi to Common (ttm)-38.76M
Diluted EPS (ttm)-1.58
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)45.53M
Total Cash Per Share (mrq)1.61
Total Debt (mrq)3.07M
Total Debt/Equity (mrq)7.32
Current Ratio (mrq)4.09
Book Value Per Share (mrq)1.48

Cash Flow Statement

Operating Cash Flow (ttm)-32.5M
Levered Free Cash Flow (ttm)-19.93M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.51
52-Week Change 3-10.20%
S&P500 52-Week Change 36.11%
52 Week High 311.49
52 Week Low 35.13
50-Day Moving Average 37.49
200-Day Moving Average 37.66

Share Statistics

Avg Vol (3 month) 352.34k
Avg Vol (10 day) 3101.38k
Shares Outstanding 5234.96M
Float 15.03M
% Held by Insiders 119.10%
% Held by Institutions 129.11%
Shares Short (May 31, 2019) 4283.66k
Short Ratio (May 31, 2019) 45.48
Short % of Float (May 31, 2019) 4N/A
Short % of Shares Outstanding (May 31, 2019) 41.08%
Shares Short (prior month Apr 30, 2019) 4315.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A